FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/03/064725 [Registered on: 22/03/2024] Trial Registered Prospectively
Last Modified On: 21/03/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   In infertile patient ovulation induction is done by using hormones (clomiphene citrate) compared with hormones with gonodotrpins( used for enhancement of ovulation) and proceeds with artificial insemination. 
Scientific Title of Study   “Comparison of clomiphene citrate with clomiphene citrate and gonadotropins in women with unexplained infertility undergoing intrauterine insemination – A Randomized control trial 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Subashree 
Designation  postgraduate 
Affiliation  sri manakula vianayagar medical college 
Address  No 61 , veerapachariya Street, Jothi nagar, ok palayam, mudaliarpet.

Pondicherry
PONDICHERRY
605004
India 
Phone  9003878935  
Fax    
Email  subashree0723@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DrJayasree 
Designation  PROFESSOR 
Affiliation  sri manakula vianayagar medical college 
Address  No 68, department of obstetrics and gynaecology sri manakula vinayagar medical college and hospital kalitheerthalkuppam madagadipet puducherry 605107

Pondicherry
PONDICHERRY
605107
India 
Phone  9443769196  
Fax    
Email  obg.jayasreem@smvmch.ac.in  
 
Details of Contact Person
Public Query
 
Name  DrJayasree 
Designation  PROFESSOR 
Affiliation  sri manakula vianayagar medical college 
Address  sri manakula vinayagar medical college and hospital kalitheerthalkuppam madagadipet puducherry 605107
sri manakula vinayagar medical college and hospital kalitheerthalkuppam,madagadipet puducherry 605107
Pondicherry
PONDICHERRY
605107
India 
Phone  9443769196  
Fax    
Email  obg.jayasreem@smvmch.ac.in  
 
Source of Monetary or Material Support  
Subashree SRI MANAKULA VINAYAGAR MEDICAL COLLEGE Kalitheerthalkuppam, Puducherry Kalitheerthalkuppam Puducherry  
 
Primary Sponsor  
Name  Sri Manukula Vinayagar Medical College  
Address  SMVMCH, MADAGADIPET, KALITHEERTHALKUPPAM,PUDUCHERRY 605107 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
SUBASHREE  SRI MANAKULA VINAYAGAR MEDICAL COLLEGE AND HOSPITAL   DEPARTMENT OF OBSTETRICS AND GYNECCOLOGY ROOM NO 68 PONDICHERRY
Pondicherry
PONDICHERRY 
9003878935

SUBASHREE0723@GMAIL.COM 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SMVMCH-ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: 1||Obstetrics,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  clomiphene citrate  Participants will receive clomiphene citrate 100mg from day 2 of the menstrual cycle for 5 days. 
Intervention  CLOMIPHENE CITRATE AMD GONODOTROPINS  patients will receive Clomiphene citrate 100 mg from day 3 of the menstrual cycle for 5 days followed by human menopausal gonadotropins (HMG) 75 IU from day 8 of the menstrual cycle till the follicle reaches 18mm size 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  40.00 Year(s)
Gender  Female 
Details  Age between 18 – 40 years
- Unexplained infertility for more than 2 years
- Normal ovulation proved by mid luteal serum progesterone level >5 ng/ml,
- Patent fallopian tubes confirmed by hysterosalpingography or laparoscopy or saline
infusion sonography
- Normal semen analysis according to the modified World Health Organization (WHO)
criteria
- Normal hormonal profile (FSH, LH, prolactin and TSH) in the early follicular phase. 
 
ExclusionCriteria 
Details  Age >40 years
- Any cause of infertility male factor, tubal or ovaria
- Any contraindication for used drugs
- Women with co-morbidities 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
The primary outcomes will be the number and size of follicles in each ovary  8 DAYS 
 
Secondary Outcome  
Outcome  TimePoints 
THE SECONDARY OUTCOME WILL BE POSITIVE PREGNANCY TEST  1 MONTH 
 
Target Sample Size   Total Sample Size="52"
Sample Size from India="52" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   31/03/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Closed to Recruitment of Participants 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   IN THIS STUDY,  Time to conceive and cost effectiveness will improve in women with unexplained infertility if it is proved that sequential treatment is better than oral agents alone for ovulation induction. 
Close